BR112018010671A8 - dispositivos e métodos de distribuição de fármaco com mudança de forma - Google Patents
dispositivos e métodos de distribuição de fármaco com mudança de formaInfo
- Publication number
- BR112018010671A8 BR112018010671A8 BR112018010671A BR112018010671A BR112018010671A8 BR 112018010671 A8 BR112018010671 A8 BR 112018010671A8 BR 112018010671 A BR112018010671 A BR 112018010671A BR 112018010671 A BR112018010671 A BR 112018010671A BR 112018010671 A8 BR112018010671 A8 BR 112018010671A8
- Authority
- BR
- Brazil
- Prior art keywords
- drug delivery
- shape
- delivery devices
- methods
- changing drug
- Prior art date
Links
- 238000012377 drug delivery Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562260068P | 2015-11-25 | 2015-11-25 | |
| US201662319033P | 2016-04-06 | 2016-04-06 | |
| PCT/US2016/063633 WO2017091749A1 (en) | 2015-11-25 | 2016-11-23 | Shape changing drug delivery devices and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112018010671A2 BR112018010671A2 (pt) | 2018-11-13 |
| BR112018010671A8 true BR112018010671A8 (pt) | 2019-02-26 |
Family
ID=57590829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018010671A BR112018010671A8 (pt) | 2015-11-25 | 2016-11-23 | dispositivos e métodos de distribuição de fármaco com mudança de forma |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US10420724B2 (enExample) |
| EP (1) | EP3380077A1 (enExample) |
| JP (1) | JP2018536484A (enExample) |
| KR (1) | KR20180086468A (enExample) |
| CN (1) | CN108601725B (enExample) |
| AU (1) | AU2016361579B2 (enExample) |
| BR (1) | BR112018010671A8 (enExample) |
| CA (1) | CA3006303C (enExample) |
| IL (1) | IL259530A (enExample) |
| WO (1) | WO2017091749A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3233056B1 (en) | 2014-12-15 | 2023-11-15 | The Johns Hopkins University | Sunitinib formulations and methods for use thereof in treatment of ocular disorders |
| WO2016176333A1 (en) | 2015-04-27 | 2016-11-03 | Reflex Medical, Inc. | Systems and mehtods for sympathetic cardiopulmonary neuromodulation |
| US11458041B2 (en) | 2015-10-08 | 2022-10-04 | Ocular Therapeutix, Inc. | Punctal plug and bioadhesives |
| BR112018009644A2 (pt) | 2015-11-12 | 2018-11-06 | Graybug Vision Inc | micropartículas agregantes sólidas modificadas na superfície, material injetável, processo para preparação de micropartículas agregantes sólidas modificadas na superfície, método para tratamento de um distúrbio ocular, e, uso de micropartículas agregantes sólidas modificadas na superfície |
| AU2016361579B2 (en) | 2015-11-25 | 2022-08-04 | Incept, Llc | Shape changing drug delivery devices and methods |
| US11246879B2 (en) | 2016-02-09 | 2022-02-15 | Tulai Therapeutics, Inc. | Methods, agents, and devices for local neuromodulation of autonomic nerves |
| WO2018005848A1 (en) | 2016-06-29 | 2018-01-04 | Bright, Corinne | Treatment of sepsis and related inflammatory conditions by local neuromodulation of the autonomic nervous system |
| KR102520771B1 (ko) | 2016-09-23 | 2023-04-12 | 인셉트, 엘엘씨 | 전안방내 약물 전달 데포 |
| CN111201040A (zh) | 2017-05-10 | 2020-05-26 | 灰色视觉公司 | 用于医学疗法的缓释微粒及其悬浮液 |
| CN108744048B (zh) * | 2018-06-29 | 2020-11-13 | 重庆科技学院 | 一种可实现自卷曲的双层水凝胶及其制备方法 |
| CA3105343A1 (en) | 2018-07-02 | 2020-01-09 | Corinne Bright | Methods and devices for in situ formed nerve cap |
| US20210315587A1 (en) | 2018-07-02 | 2021-10-14 | Tulavi Therapeutics, Inc. | Methods and devices for in situ formed nerve cap with rapid release |
| JP7624269B2 (ja) * | 2018-11-09 | 2025-01-30 | タリス バイオメディカル エルエルシー | 上部尿路への局所薬物送達のための薬物送達装置及びシステム |
| CN109350355B (zh) * | 2018-11-30 | 2023-09-12 | 西安市第四医院 | 一种smile手术来源角膜基质透镜泪道栓及其制备方法 |
| US11523896B2 (en) | 2019-05-02 | 2022-12-13 | Kevin L. Waltz | Ocular protection ring |
| CN111150545A (zh) * | 2020-01-02 | 2020-05-15 | 首都医科大学附属北京同仁医院 | 一种相变降温支架及其制备方法和相变降温组合支架 |
| DK3861985T3 (da) | 2020-02-06 | 2023-07-24 | Ocular Therapeutix Inc | Sammensætninger og fremgangsmåder til behandling af øjensygdomme |
| DK3884929T3 (da) | 2020-03-25 | 2023-09-25 | Ocular Therapeutix Inc | Øjenimplantat indeholdende en tyrosinkinase-inhibitor |
| CN115768385A (zh) | 2020-04-27 | 2023-03-07 | 视觉治疗股份有限公司 | 治疗过敏性结膜炎的方法 |
| WO2022066891A1 (en) | 2020-09-24 | 2022-03-31 | Ocular Therapeutix, Inc. | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent |
| BR112023004378A2 (pt) | 2020-09-24 | 2023-04-04 | Ocular Therapeutix Inc | Insertos intracanaliculares biodegradáveis de liberação sustentada que compreendem um hidrogel e uma ciclosporina |
| EP4590593A2 (en) * | 2022-09-25 | 2025-07-30 | Albert-Ludwigs-Universität Freiburg | Marine polysaccharide networks |
| WO2024215649A1 (en) | 2023-04-11 | 2024-10-17 | Ocular Therapeutix, Inc. | Ocular implant comprising axitinib polymorph iv |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1014335A (en) | 1910-11-10 | 1912-01-09 | Union Typewriter Co | Type-writing machine. |
| US3640741A (en) | 1970-02-24 | 1972-02-08 | Hollister Inc | Composition containing gel |
| US3865108A (en) | 1971-05-17 | 1975-02-11 | Ortho Pharma Corp | Expandable drug delivery device |
| US4002173A (en) | 1974-07-23 | 1977-01-11 | International Paper Company | Diester crosslinked polyglucan hydrogels and reticulated sponges thereof |
| DE2437629C3 (de) | 1974-08-05 | 1978-09-21 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von unlöslichen in Wasser nur wenig quellbaren Polymerisaten von N-Vinyllactamen |
| US4014335A (en) | 1975-04-21 | 1977-03-29 | Alza Corporation | Ocular drug delivery device |
| US4207893A (en) | 1977-08-29 | 1980-06-17 | Alza Corporation | Device using hydrophilic polymer for delivering drug to biological environment |
| US4484922A (en) | 1981-06-25 | 1984-11-27 | Rosenwald Peter L | Occular device |
| US5160745A (en) | 1986-05-16 | 1992-11-03 | The University Of Kentucky Research Foundation | Biodegradable microspheres as a carrier for macromolecules |
| US4741872A (en) | 1986-05-16 | 1988-05-03 | The University Of Kentucky Research Foundation | Preparation of biodegradable microspheres useful as carriers for macromolecules |
| IL82834A (en) | 1987-06-09 | 1990-11-05 | Yissum Res Dev Co | Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom |
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| US5304595A (en) | 1988-11-21 | 1994-04-19 | Collagen Corporation | Collagen-polymer conjugates |
| US5162430A (en) | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
| IL90193A (en) | 1989-05-04 | 1993-02-21 | Biomedical Polymers Int | Polurethane-based polymeric materials and biomedical articles and pharmaceutical compositions utilizing the same |
| US5410016A (en) | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| JP3165734B2 (ja) * | 1992-05-19 | 2001-05-14 | テルモ株式会社 | 新規な高吸水形状記憶材料 |
| US5304959A (en) | 1992-10-16 | 1994-04-19 | Spectrian, Inc. | Planar microstrip balun |
| US6566406B1 (en) | 1998-12-04 | 2003-05-20 | Incept, Llc | Biocompatible crosslinked polymers |
| US6371975B2 (en) | 1998-11-06 | 2002-04-16 | Neomend, Inc. | Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers |
| EP1027016A4 (en) | 1997-10-27 | 2006-03-08 | Univ California | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REFERRING RETINAL RIPPLE |
| US6605294B2 (en) | 1998-08-14 | 2003-08-12 | Incept Llc | Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels |
| US6152943A (en) | 1998-08-14 | 2000-11-28 | Incept Llc | Methods and apparatus for intraluminal deposition of hydrogels |
| US6632457B1 (en) | 1998-08-14 | 2003-10-14 | Incept Llc | Composite hydrogel drug delivery systems |
| US6514534B1 (en) | 1998-08-14 | 2003-02-04 | Incept Llc | Methods for forming regional tissue adherent barriers and drug delivery systems |
| US6958212B1 (en) | 1999-02-01 | 2005-10-25 | Eidgenossische Technische Hochschule Zurich | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| WO2002017831A2 (en) * | 2000-08-30 | 2002-03-07 | John Hopkins University | Devices for intraocular drug delivery |
| MXPA03007665A (es) | 2001-02-26 | 2004-03-16 | Univ Duke | Polimeros dendriticos novedosos y sus usos biomedicos. |
| US20040131582A1 (en) | 2002-02-26 | 2004-07-08 | Grinstaff Mark W. | Novel dendritic polymers and their biomedical uses |
| US7129210B2 (en) | 2003-07-23 | 2006-10-31 | Covalent Medical, Inc. | Tissue adhesive sealant |
| CA2539324A1 (en) * | 2003-09-18 | 2005-03-31 | Macusight, Inc. | Transscleral delivery |
| WO2006031358A2 (en) | 2004-08-13 | 2006-03-23 | Hyperbranch Medical Technology, Inc. | Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses |
| WO2006031388A2 (en) | 2004-08-20 | 2006-03-23 | Hyperbranch Medical Technology, Inc. | Dentritic polymers, crosslinked gels, and their uses in orthopedic applications |
| WO2007001926A2 (en) | 2005-06-24 | 2007-01-04 | Hyperbranch Medical Technology, Inc. | Low-swelling hydrogel sealants for wound repair |
| WO2007005249A2 (en) | 2005-06-29 | 2007-01-11 | Hyperbranch Medical Technology, Inc. | Nanoparticles and dendritic-polymer-based hydrogels comprising them |
| US8795709B2 (en) | 2006-03-29 | 2014-08-05 | Incept Llc | Superabsorbent, freeze dried hydrogels for medical applications |
| US20080220047A1 (en) * | 2007-03-05 | 2008-09-11 | Sawhney Amarpreet S | Low-swelling biocompatible hydrogels |
| US20080287633A1 (en) * | 2007-05-18 | 2008-11-20 | Drumheller Paul D | Hydrogel Materials |
| US9125807B2 (en) | 2007-07-09 | 2015-09-08 | Incept Llc | Adhesive hydrogels for ophthalmic drug delivery |
| US8409606B2 (en) * | 2009-02-12 | 2013-04-02 | Incept, Llc | Drug delivery through hydrogel plugs |
| EP3960215B1 (en) | 2009-12-15 | 2024-10-16 | Incept, LLC | Implants and biodegradable fiducial markers |
| US8961501B2 (en) | 2010-09-17 | 2015-02-24 | Incept, Llc | Method for applying flowable hydrogels to a cornea |
| EP2699317B1 (en) | 2011-04-21 | 2016-08-10 | Mapi Pharma Limited | Random pentapolymer for treatment of autoimmune diseases |
| WO2012150265A1 (en) * | 2011-05-02 | 2012-11-08 | Dsm Ip Assets B.V. | Fiber comprising a biodegradable polymer |
| AU2012308317B2 (en) | 2011-09-14 | 2017-01-05 | Forsight Vision5, Inc. | Ocular insert apparatus and methods |
| US10226417B2 (en) | 2011-09-16 | 2019-03-12 | Peter Jarrett | Drug delivery systems and applications |
| AU2012347926B2 (en) | 2011-12-05 | 2018-03-15 | Incept, Llc | Medical organogel processes and compositions |
| SI2911623T1 (sl) | 2012-10-26 | 2019-12-31 | Forsight Vision5, Inc. | Oftalmični sistem za podaljšano sproščanje zdravila v oko |
| US20160166504A1 (en) | 2014-12-10 | 2016-06-16 | Incept, Llc | Hydrogel drug delivery implants |
| JP2018515529A (ja) | 2015-05-12 | 2018-06-14 | インセプト・リミテッド・ライアビリティ・カンパニーＩｎｃｅｐｔ，Ｌｌｃ | ハイドロゲルからの薬物送達 |
| AU2016297642A1 (en) | 2015-07-22 | 2018-02-15 | Incept, Llc | Coated punctal plug |
| AU2016361579B2 (en) * | 2015-11-25 | 2022-08-04 | Incept, Llc | Shape changing drug delivery devices and methods |
-
2016
- 2016-11-23 AU AU2016361579A patent/AU2016361579B2/en active Active
- 2016-11-23 US US15/360,430 patent/US10420724B2/en active Active
- 2016-11-23 WO PCT/US2016/063633 patent/WO2017091749A1/en not_active Ceased
- 2016-11-23 BR BR112018010671A patent/BR112018010671A8/pt not_active Application Discontinuation
- 2016-11-23 EP EP16816493.7A patent/EP3380077A1/en active Pending
- 2016-11-23 CN CN201680078805.5A patent/CN108601725B/zh active Active
- 2016-11-23 KR KR1020187017686A patent/KR20180086468A/ko not_active Abandoned
- 2016-11-23 CA CA3006303A patent/CA3006303C/en active Active
- 2016-11-23 JP JP2018526903A patent/JP2018536484A/ja active Pending
-
2018
- 2018-05-22 IL IL259530A patent/IL259530A/en unknown
-
2019
- 2019-08-06 US US16/533,331 patent/US10786462B2/en active Active
-
2020
- 2020-08-21 US US16/999,504 patent/US11413250B2/en active Active
-
2022
- 2022-07-07 US US17/859,820 patent/US11938223B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11938223B2 (en) | 2024-03-26 |
| KR20180086468A (ko) | 2018-07-31 |
| CN108601725B (zh) | 2024-03-08 |
| WO2017091749A8 (en) | 2017-07-06 |
| EP3380077A1 (en) | 2018-10-03 |
| US20200030241A1 (en) | 2020-01-30 |
| WO2017091749A1 (en) | 2017-06-01 |
| US10420724B2 (en) | 2019-09-24 |
| US20170143636A1 (en) | 2017-05-25 |
| AU2016361579A1 (en) | 2018-06-21 |
| JP2018536484A (ja) | 2018-12-13 |
| US11413250B2 (en) | 2022-08-16 |
| CA3006303C (en) | 2023-11-14 |
| AU2016361579B2 (en) | 2022-08-04 |
| CN108601725A (zh) | 2018-09-28 |
| BR112018010671A2 (pt) | 2018-11-13 |
| US20210128478A1 (en) | 2021-05-06 |
| US20220339108A1 (en) | 2022-10-27 |
| US10786462B2 (en) | 2020-09-29 |
| IL259530A (en) | 2018-07-31 |
| CA3006303A1 (en) | 2017-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018010671A8 (pt) | dispositivos e métodos de distribuição de fármaco com mudança de forma | |
| CY1124729T1 (el) | Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου | |
| NI201600071A (es) | Compuestos de inhibidor de autotaxina | |
| BR112018076601A2 (pt) | formulação farmacêutica oral, métodos para tratar um paciente, e, uso de uma formulação | |
| MX2015009104A (es) | Composiciones en solución sólida y uso en el tratamiento de enfermedades cardiovasculares. | |
| MX2018003388A (es) | Agonistas del receptor farnesoide x y usos de los mismos. | |
| PL3687513T3 (pl) | Leczenie zespołu łamliwego chromosomu x i autyzmu z użyciem kannabidiolu | |
| BR112016020618A8 (pt) | oligômero antissentido, composição farmacêutica, e, uso de um oligômero antissentido | |
| BR112016002646A2 (pt) | dispositivos e métodos de entrega de fármaco de múltiplas unidades | |
| BR112017005693A2 (pt) | método para tratar e/ou prevenir uma doença hepática, e, composição farmacêutica. | |
| CL2015002733A1 (es) | Composición farmacéutica de clorhidrato de s-cetamina. | |
| BR112015022625A2 (pt) | micromatrizes para entrega de agente terapêutico e métodos de uso | |
| CL2016001609A1 (es) | Composiciones farmacéuticas que comprenden azd9291. | |
| CR20150326A (es) | Inhibidores de autotaxina | |
| NI201600070A (es) | Inhibidores tetracíclicos de autotaxina | |
| PL3381451T3 (pl) | Kompozycja farmaceutyczna stosowana do redukcji zlokalizowanej tkanki tłuszczowej i zastosowanie kompozycji farmaceutycznej | |
| ZA201508454B (en) | Method of applying a composition and pharmaceutical composition with a regimen of administering it, including photo-activating the active component | |
| CO2017002472A2 (es) | Formulación de acetato de abiraterona | |
| MX2015009269A (es) | Composiciones farmaceuticas que comprenden donadores de nitroxilo. | |
| CL2015002180A1 (es) | Terapia de combinación para el tratamiento de neumonía nosocomial | |
| BR112017012406A2 (pt) | formulação com relação fixa de insulina glargina/lixisenatida | |
| EP2968368A4 (en) | CRANIAL DISTRIBUTION OF MEDICINAL PRODUCTS | |
| BR112017024908A2 (pt) | usos terapêuticos da 4-cloroquinurenina | |
| ECSP16086247A (es) | (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
| BR112015024703A2 (pt) | formulação farmacêutica, método de tratamento e/ou prevenção de restenose e kit para o tratamento e/ou prevenção de restenose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO EM FUNCAO DA REVOGACAO DO ART. 229-C DA LEI NO 9.279, DE 1996, POR FORCA DA LEI NO 14.195, DE 2021 |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |